ARTICLE | Distillery Therapeutics
Endocrine / Metabolic
December 6, 2016 7:35 PM UTC
Mouse and cell culture studies suggest inhibiting GPAT3 and/or GPAT4 could help treat congenital generalized lipodystrophy type 2, which is caused by mutations in BSCL2. In a mouse model of the diseas...